Clinical Trial Update: The Predictability of CD19 Expression Across Primitive Cellular Fractions of Relapsed B-ALL on Outcomes of CD19-targeted CAR T-cells

View source ↗

Summary

This clinical trial explores how CD19 expression across primitive cellular fractions in relapsed B-cell acute lymphoblastic leukemia affects outcomes of CD19-ta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19-targeted CAR-T cell therapy

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Relapsed B-ALL, CAR T-cells | Status: NOT_YET_RECRUITING